Loading...

Minerva Surgical, Inc.

UTRS•NASDAQ
HealthcareMedical - Healthcare Information Services
$0.00
$0.00(0.00%)

Minerva Surgical, Inc. (UTRS) Stock Overview

Explore Minerva Surgical, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for UTRSStats details for UTRS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for UTRSAnalyst Recommendations details for UTRS are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

CEO

Mr. Darin Hammers

Employees

174

Headquarters

4255 Burton Drive, Santa Clara, CA

Founded

2021

Frequently Asked Questions